{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T07:52:44Z","timestamp":1766908364755,"version":"build-2065373602"},"reference-count":66,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The cornea, while appearing to be simple tissue, is actually an extremely complex structure. In order for it to retain its biomechanical and optical properties, perfect organization of its cells is essential. Proper regeneration is especially important after injuries and in the course of various diseases. Eph receptors and ephrin are mainly responsible for the proper organization of tissues as well as cell migration and communication. In this review, we present the current state of knowledge on the role of Eph and ephrins in corneal physiology and diseases, in particular, we focused on the functions of the epithelium and endothelium. Since the role of Eph and ephrins in the angiogenesis process has been well established, we also analyzed their influence on conditions with corneal neovascularization.<\/jats:p>","DOI":"10.3390\/ijms22094567","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T06:19:11Z","timestamp":1619504351000},"page":"4567","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Role of Eph Receptors and Ephrins in Corneal Physiology and Diseases"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9920-4406","authenticated-orcid":false,"given":"Radoslaw","family":"Kaczmarek","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Zimmer","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3967-7169","authenticated-orcid":false,"given":"Pawel","family":"Gajdzis","sequence":"additional","affiliation":[{"name":"Department of Pathomorphology and Oncological Cytology, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malgorzata","family":"Gajdzis","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cell.2008.03.011","article-title":"Eph-Ephrin Bidirectional Signaling in Physiology and Disease","volume":"133","author":"Pasquale","year":"2008","journal-title":"Cell"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1111\/j.1582-4934.2012.01612.x","article-title":"Eph receptors and ephrins as targets for cancer therapy","volume":"16","author":"Xi","year":"2012","journal-title":"J. Cell. Mol. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s00018-011-0900-6","article-title":"Eph-dependent cell-cell adhesion and segregation in development and cancer","volume":"69","author":"Nievergall","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cytogfr.2004.09.002","article-title":"The role of ephrins and Eph receptors in cancer","volume":"15","author":"Surawska","year":"2004","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s00018-003-2297-3","article-title":"Vascular integrins: Pleiotropic adhesion and signaling molecules in vascular homeostasis and angiogenesis","volume":"60","author":"Mariotti","year":"2003","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.12688\/f1000research.7417.1","article-title":"Eph-ephrin signaling in nervous system development","volume":"5","author":"Cramer","year":"2016","journal-title":"F1000Research"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.1038\/sj.onc.1204004","article-title":"The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization","volume":"19","author":"Ogawa","year":"2000","journal-title":"Oncogene"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4161\/19336918.2014.970012","article-title":"Eph receptor and ephrin function in breast, gut, and skin epithelia","volume":"8","author":"Getsios","year":"2014","journal-title":"Cell Adh. Migr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1242\/jcs.030627","article-title":"Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytes","volume":"121","author":"Pfaff","year":"2008","journal-title":"J. Cell Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.drudis.2013.11.017","article-title":"Therapeutic perspectives of Eph\u2013ephrin system modulation","volume":"19","author":"Tognolini","year":"2014","journal-title":"Drug Discov. Today"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1146\/annurev-pharmtox-011112-140226","article-title":"Eph receptors and ephrins: Therapeutic opportunities","volume":"55","author":"Barquilla","year":"2015","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jcrs.2010.12.037","article-title":"Anatomy and physiology of the cornea","volume":"37","author":"DelMonte","year":"2011","journal-title":"J. Cataract Refract. Surg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.clae.2019.04.018","article-title":"The refractive index of the human cornea: A review","volume":"42","author":"Patel","year":"2019","journal-title":"Contact Lens Anterior Eye"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1167\/iovs.03-0131","article-title":"Collagen fibrils appear more closely packed in the prepupillary cornea: Optical and biomechanical implications","volume":"44","author":"Boote","year":"2003","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/02713689109001742","article-title":"The developing corneal endothelium: Correlation of morphology, hydration and na\/k ATPase pump site density","volume":"10","author":"Stiemke","year":"1991","journal-title":"Curr. Eye Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.07.001","article-title":"Corneal structure and transparency","volume":"49","author":"Meek","year":"2015","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/ICO.0b013e3180335526","article-title":"Comparison of EphA receptor tyrosine kinases and ephrinA ligand expression to EphB-ephrinB in vascularized corneas","volume":"26","author":"Kojima","year":"2007","journal-title":"Cornea"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neuroscience.2005.05.052","article-title":"High EphA3 expressing ophthalmic trigeminal sensory axons are sensitive to ephrin-A5-Fc: Implications for lobe specific axon guidance","volume":"135","author":"Jayasena","year":"2005","journal-title":"Neuroscience"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.exer.2018.02.017","article-title":"A potential role for Eph receptor signalling during migration of corneal endothelial cells","volume":"170","author":"Walshe","year":"2018","journal-title":"Exp. Eye Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.exer.2012.11.016","article-title":"Evaluation of Eph receptor and ephrin expression within the human cornea and limbus","volume":"107","author":"Hogerheyde","year":"2013","journal-title":"Exp. Eye Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1167\/iovs.11-8685","article-title":"EphA2\/ephrin-A1 signaling complexes restrict corneal epithelial cell migration","volume":"53","author":"Kaplan","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"108094","DOI":"10.1016\/j.exer.2020.108094","article-title":"Corneal epithelial biology: Lessons stemming from old to new","volume":"198","author":"Lavker","year":"2020","journal-title":"Exp. Eye Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jtos.2019.06.007","article-title":"The impact of hyperglycemia on the corneal epithelium: Molecular mechanisms and insight","volume":"17","author":"Zhu","year":"2019","journal-title":"Ocul. Surf."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1038\/nutd.2017.4","article-title":"A systematic review on the impact of diabetes mellitus on the ocular surface","volume":"7","author":"Shih","year":"2017","journal-title":"Nutr. Diabetes"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1167\/iovs.10-5670","article-title":"Impaired epithelial wound healing and EGFR signaling pathways in the corneas of diabetic rats","volume":"52","author":"Xu","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1167\/iovs.17-22941","article-title":"Epha2\/ephrin-A1 mediate corneal epithelial cell compartmentalization via ADAM10 regulation of EGFR signaling","volume":"59","author":"Kaplan","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.exer.2003.09.008","article-title":"Corneal epithelial stem cells at the limbus: Looking at some old problems from a new angle","volume":"78","author":"Lavker","year":"2004","journal-title":"Exp. Eye Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3109\/02713683.2013.823212","article-title":"Progress in the pathogenesis of pterygium","volume":"38","author":"Liu","year":"2013","journal-title":"Curr. Eye Res."},{"key":"ref_29","first-page":"55","article-title":"Microarray and protein analysis of human pterygium","volume":"23","year":"2006","journal-title":"Mol. Vis."},{"key":"ref_30","first-page":"837","article-title":"Angiogenesis in the pathogenesis of pterygium","volume":"52","author":"Livezeanu","year":"2011","journal-title":"Rom. J. Morphol. Embryol."},{"key":"ref_31","first-page":"4008","article-title":"EphB4 expression in pterygium is associated with microvessel density","volume":"7","author":"Xue","year":"2014","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3129\/i09-005","article-title":"EphrinB2 and EphB4 expression in pterygia: New insights and preliminary results","volume":"44","author":"Xue","year":"2009","journal-title":"Can. J. Ophthalmol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.preteyeres.2007.02.001","article-title":"The human corneal endothelium: New insights into electrophysiology and ion channels","volume":"26","author":"Mergler","year":"2007","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2353\/ajpath.2006.050435","article-title":"EphrinA1 inhibits vascular endothelial growth factor-induced intracellular signaling and suppresses retinal neovascularization and blood-retinal barrier breakdown","volume":"168","author":"Ojima","year":"2006","journal-title":"Am. J. Pathol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2217\/rme-2018-0105","article-title":"Current strategies for human corneal endothelial regeneration","volume":"14","author":"White","year":"2019","journal-title":"Regen. Med."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Giorgio, C., Mohamed, I.H., Flammini, L., Barocelli, E., Incerti, M., Lodola, A., and Tognolini, M. (2011). Lithocholic Acid Is an Eph-ephrin Ligand Interfering with Eph-kinase Activation. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0018128"},{"key":"ref_37","first-page":"264","article-title":"Corneal angiogenic privilege: Angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (An American Ophthalmological Society Thesis)","volume":"104","author":"Azar","year":"2006","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.22336\/rjo.2019.4","article-title":"Corneal neovascularization: Updates on pathophysiology, investigations & management","volume":"63","author":"Sharif","year":"2019","journal-title":"Rom. J. Ophthalmol."},{"key":"ref_39","first-page":"182","article-title":"Clinical correlates of common corneal neovascular diseases: A literature review","volume":"8","author":"Abdelfattah","year":"2015","journal-title":"Int. J. Ophthalmol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","article-title":"Ocular neovascularization: An epidemiologic review","volume":"43","author":"Lee","year":"1998","journal-title":"Surv. Ophthalmol."},{"key":"ref_41","first-page":"193","article-title":"Contact lens-related complications: A review","volume":"12","author":"Alipour","year":"2017","journal-title":"J. Ophthalmic Vis. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4321\/S0365-66912006000600002","article-title":"Corneal vascularisation and contact lenses","volume":"81","author":"Papas","year":"2006","journal-title":"Arch. Soc. Esp. Oftalmol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/ICO.0b013e318201405a","article-title":"Treatments for corneal neovascularization: A review","volume":"30","author":"Gupta","year":"2011","journal-title":"Cornea"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.preteyeres.2010.01.002","article-title":"Novel aspects of corneal angiogenic and lymphangiogenic privilege","volume":"29","author":"Ellenberg","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1023\/B:AGEN.0000037340.33788.87","article-title":"Eph receptor tyrosine kinases in angiogenesis: From development to disease","volume":"7","author":"Chen","year":"2004","journal-title":"Angiogenesis"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1476-4598-1-2","article-title":"Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis","volume":"1","author":"Cheng","year":"2002","journal-title":"Mol. Cancer Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.tcm.2007.03.003","article-title":"Regulation of Angiogenesis by Eph\u2013Ephrin Interactions","volume":"17","author":"Kuijper","year":"2007","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_48","first-page":"1625","article-title":"A model of Angiogenesis in the Mouse Cornea","volume":"37","author":"Kenyon","year":"1996","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1161\/01.ATV.0000096655.56262.56","article-title":"Ephrin-B2 Induces Migration of Endothelial Cells through the Phosphatidylinositol-3 Kinase Pathway and Promotes Angiogenesis in Adult Vasculature","volume":"23","author":"Maekawa","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1161\/01.CIR.0000163566.07427.73","article-title":"Functional ephrin-B2 expression for promotive interaction between arterial and venous vessels in postnatal neovascularization","volume":"111","author":"Hayashi","year":"2005","journal-title":"Circulation"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1242\/jcs.115.15.3073","article-title":"Ephrin-B1 transduces signals to activate integrin-mediated migration, attachment and angiogenesis","volume":"115","author":"Vindis","year":"2002","journal-title":"J. Cell Sci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1126\/science.7536959","article-title":"Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-\u03b1-induced angiogenesis","volume":"268","author":"Pandey","year":"1995","journal-title":"Science"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-319-91439-8_2","article-title":"Dasatinib","volume":"212","author":"Lindauer","year":"2018","journal-title":"Recent Results Cancer Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1167\/iovs.05-0502","article-title":"Soluble EphB4 regulates choroidal endothelial cell function and inhibits laser-induced choroidal neovascularization","volume":"46","author":"He","year":"2005","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.mvr.2009.01.013","article-title":"Soluble ephrin-B2 mediates apoptosis in retinal neovascularization and in endothelial cells","volume":"77","author":"Davies","year":"2009","journal-title":"Microvasc. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1167\/iovs.04-0983","article-title":"Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy","volume":"46","author":"Zamora","year":"2005","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1755-3768.2009.01609.x","article-title":"Therapeutic interference with EphrinB2 signalling inhibits oxygen-induced angioproliferative retinopathy","volume":"89","author":"Ehlken","year":"2011","journal-title":"Acta Ophthalmol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1136\/bjo.2010.182881","article-title":"Ocular safety profile and intraocular pharmacokinetics of an antagonist of EphB4\/EphrinB2 signalling","volume":"94","author":"Brar","year":"2010","journal-title":"Br. J. Ophthalmol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-3-319-95046-4_48","article-title":"Drug-induced retinal toxicity","volume":"1085","author":"Tsang","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e00545","DOI":"10.1002\/prp2.545","article-title":"Species differences in ocular pharmacokinetics and pharmacological activities of regorafenib and pazopanib eye-drops among rats, rabbits and monkeys","volume":"7","author":"Horita","year":"2019","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/s41551-020-00606-8","article-title":"Gelling hypotonic polymer solution for extended topical drug delivery to the eye","volume":"4","author":"Kim","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/bcp.13502","article-title":"Topical administration of regorafenib eye drops: Phase I dose-escalation study in healthy volunteers","volume":"84","author":"Zimmermann","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/s41598-018-19788-y","article-title":"Inhibition of angiogenesis by leflunomide via targeting the soluble ephrin-A1\/EphA2 system in bladder cancer","volume":"8","author":"Chu","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1158\/0008-5472.CAN-3430-2","article-title":"Antiangiogenic and Antitumor Efficacy of EphA2 Receptor Antagonist","volume":"64","author":"Dobrzanski","year":"2004","journal-title":"Cancer Res."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Janes, P.W., Vail, M.E., Gan, H.K., and Scott, A.M. (2020). Antibody targeting of eph receptors in cancer. Pharmaceuticals, 13.","DOI":"10.3390\/ph13050088"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/bs.acr.2020.04.007","article-title":"Eph receptors as cancer targets for antibody-based therapy","volume":"147","author":"Tang","year":"2020","journal-title":"Adv. Cancer Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/9\/4567\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:53:17Z","timestamp":1760161997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/9\/4567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,27]]},"references-count":66,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["ijms22094567"],"URL":"https:\/\/doi.org\/10.3390\/ijms22094567","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2021,4,27]]}}}